References:
1. Cal M, Ayres‐de‐Campos D, Jauniaux EJIJoG, Obstetrics. International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders. 2018;140(3):307-11.
2. Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol. 2007;189(5):1158-63.
3. Ye MY, Z.;Xue, M.;Deng, X. High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta. BJOG: An International Journal of Obstetrics and Gynaecology. 2017;124:71-7.
4. Zeng C, Yang M, Ding Y, Duan S, Zhou Y. Placenta accreta spectrum disorder trends in the context of the universal two-child policy in China and the risk of hysterectomy. Int J Gynaecol Obstet. 2018;140(3):312-8.
5. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107(6):1226-32.
6. Timor-Tritsch IE, Monteagudo AJAjoo, gynecology. Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review. 2012;207(1):14-29.
7. ACOG Committee opinion. Number 266, January 2002 : placenta accreta. Obstet Gynecol. 2002;99(1):169-70.
8. Verspyck E, Resch B, Sergent F, Marpeau L. Surgical uterine devascularization for placenta accreta: immediate and long-term follow-up. Acta Obstet Gynecol Scand. 2005;84(5):444-7.
9. Legendre G, Zoulovits FJ, Kinn J, Senthiles L, Fernandez H. Conservative management of placenta accreta: hysteroscopic resection of retained tissues. J Minim Invasive Gynecol. 2014;21(5):910-3.
10. Kutuk MS, Ak M, Ozgun MT. Leaving the placenta in situ versus conservative and radical surgery in the treatment of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):338-44.
11. Sentilhes L, Kayem G, Chandraharan E, Palacios‐Jaraquemada J, Jauniaux E, Diagnosis FPA, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. 2018;140(3):291-8.
12. Jenne JW, Preusser T, Günther M. High-intensity focused ultrasound: principles, therapy guidance, simulations and applications. Z Med Phys. 2012;22(4):311-22.
13. Jang HJ, Lee J-Y, Lee D-H, Kim W-H, Hwang JHJG, liver. Current and future clinical applications of high-intensity focused ultrasound (HIFU) for pancreatic cancer. 2010;4(Suppl 1):S57.
14. Zhu X, Deng X, Wan Y, Xiao S, Huang J, Zhang L, et al. High-intensity focused ultrasound combined with suction curettage for the treatment of cesarean scar pregnancy. Medicine (Baltimore). 2015;94(18):e854.
15. Fan TY, Zhang L, Chen W, Liu Y, He M, Huang X, et al. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. Eur J Radiol. 2012;81(11):3624-30.
16. Park MJ, Kim YS, Rhim H, Lim HK. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231-9.
17. CON-PAS registry. Middle-East Obstetrics and Gynecology Graduate Education (MOGGE) Foundation. https://www.mogge-obgyn.com/con-pas-registry. Last accessed: April 28th, 2020
18. . US National Heart, Lung and Blood Institute Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group [URL: wwwnhlbinihgov/health-topics/study-quality-assessment-tools (accessed 9 April 2020]
19. Bai YL, X.;Li, Q.;Yin, N.;Fu, X.;Zhang, H.;Qi, H. High-intensity focused ultrasound treatment of placenta accreta after vaginal delivery: A preliminary study. Ultrasound in Obstetrics and Gynecology. 2016;47(4):492-8.
20. Jiang XFT, Q. L.;Yang, B. J.;Ye, F.;Cai, L.;Wang, X. Y.;Luo, X.;Bu, H. High-intensity focused ultrasound combined procedures treatment of retained placenta accreta with marked vascularity after abortion or delivery. International Journal of Hyperthermia. 2019;36(1):421-7.
21. Liu YZ, W. W.;He, M.;Gong, C.;Xie, B.;Wen, X.;Li, D.;Zhang, L. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases. Int J Hyperthermia. 2018;35(1):56-61.
22. Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta‐analysis. 2018;52(3):304-9.
23. Jauniaux E, Alfirevic Z, Bhide A, Belfort M, Burton G, Dornan S, et al. Placenta praevia and placenta accreta: diagnosis and management. Green-top Guideline No. 27a. 2018;126(1).
24. gynaecology CoOPJIjo, Gynaecology otoootIFo, Obstetrics. ACOG committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists. 2002;77(1):77.
25. Eller A, Porter T, Soisson P, Silver RJBAIJoO, Gynaecology. Optimal management strategies for placenta accreta. 2009;116(5):648-54.
26. Mohan B, Wander G, Bansal R, Mutti J, Tandon P, Juneja S, et al. Intra-operative uterine artery embolization with caesarean delivery in an adjoining operating theatre and catheter lab (OT/CL) complex vs. conventional management in patients with abnormally invasive placenta: a retrospective case control study. Journal of Obstetrics and Gynaecology. 2020;40(3):324-9.
27. Mohr‐Sasson A, Hochman R, Anteby M, Spira M, Castel E, Hendler I, et al. Cesarean delivery with and without uterine artery embolization for the management of placenta accreta spectrum disorder‐A comparative study. 2020.
28. Babaei M, Kian MO, Naderi Z, Khodaverdi S, Raoofi Z, Javanmanesh F, et al. Methotrexate infusion followed by uterine artery embolisation for the management of placental adhesive disorders: a case series. 2019;74(5):378-83.
29. Yuan Q, Jin Y, Chen L, Ling L, Bai XmJIJoG, Obstetrics. Prophylactic uterine artery embolization during cesarean delivery for placenta previa complicated by placenta accreta. 2019.
30. Pan Y, Zhou X, Yang Z, Cui S, De W, Sun LJIJoG, et al. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. 2017;137(1):45-50.
31. Wang Z-w, Li X-g, Pan J, Zhang X-b, Shi H-f, Yang N, et al. Uterine artery embolization for management of primary postpartum hemorrhage associated with placenta accreta. 2016;31(4):228-32.
32. Niola R, Giurazza F, Nazzaro G, Silvestre M, Nasti G, Di Pasquale MA, et al. Uterine artery embolization before delivery to prevent postpartum hemorrhage. 2016;27(3):376-82.
33. D’Souza DL, Kingdom JC, Amsalem H, Beecroft JR, Windrim RC, Kachura JRJCAoRJ. Conservative management of invasive placenta using combined prophylactic internal iliac artery balloon occlusion and immediate postoperative uterine artery embolization. 2015;66(2):179-84.
34. Duan X-H, Wang Y-L, Han X-W, Chen Z-M, Chu Q-J, Wang L, et al. Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. 2015;70(9):932-7.
35. Lo TK, Yung W, Lau W, Law B, Lau S, Leung WJTJoM-F, et al. Planned conservative management of placenta accreta–experience of a regional general hospital. 2014;27(3):291-6.
36. Hwang SM, Jeon GS, Kim MD, Kim SH, Lee JT, Choi MJJEr. Transcatheter arterial embolisation for the management of obstetric haemorrhage associated with placental abnormality in 40 cases. 2013;23(3):766-73.
37. Chung MY, Cheng YK, Yu SC, Sahota DS, Leung TYJAoegS. Nonremoval of an abnormally invasive placenta at cesarean section with postoperative uterine artery embolization. 2013;92(11):1250-5.
38. Meyer N, Ward G, Chandraharan EJCMJ. Conservative approach to the management of morbidly adherent placentae. 2012;57(1).
39. Li X, Wang Z, Chen J, Shi H, Zhang X, Pan J, et al. Uterine artery embolization for the management of secondary postpartum haemorrhage associated with placenta accreta. 2012;67(12):e71-e6.
40. Bouvier A, Sentilhes L, Thouveny F, Bouet P-E, Gillard P, Willoteaux S, et al. Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. 2012;67(11):1089-94.
41. Soyer P, Morel O, Fargeaudou Y, Sirol M, Staub F, Boudiaf M, et al. Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta. 2011;80(3):729-35.
42. Barber Jr JT, Tressler TB, Willis GS, Martinez FJ, Peisner DB, Goodman JD, et al. Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy. 2011;204(5):e4-e8.
43. Jung HN, Shin SW, Choi S-J, Cho SK, Park KB, Park HS, et al. Uterine artery embolization for emergent management of postpartum hemorrhage associated with placenta accreta. 2011;52(6):638-42.
44. Park JK, Shin TB, Baek JC, Shin JK, Choi WJ, Lee SA, et al. Failure of uterine artery embolization for controlling postpartum hemorrhage. 2011;37(8):971-8.
45. Sivan E, Spira M, Achiron R, Rimon U, Golan G, Mazaki-Tovi S, et al. Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: can it prevent cesarean hysterectomy? 2010;27(06):455-61.
46. Yu M, Liu X, Dai Q, Cui Q, Jin Z, Lang JJZyxkxyxbAAMS. Diagnosis and treatment of placenta accreta in the second trimester of pregnancy. 2010;32(5):501-4.
47. Diop AN, Chabrot P, Bertrand A, Constantin JM, Cassagnes L, Storme B, et al. Placenta accreta: management with uterine artery embolization in 17 cases. 2010;21(5):644-8.
48. Sentilhes L, Gromez A, Clavier E, Resch B, Verspyck E, Marpeau LJO, et al. Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. 2009;113(5):992-9.
49. Chen M, Liu X, You Y, Wang X, Li T, Luo H, et al. Internal Iliac Artery Balloon Occlusion for Placenta Previa and Suspected Placenta Accreta: A Randomized Controlled Trial. 2020;135(5):1112-9.
50. Liu J, Wang Y, Jiao D, Zhang W, Han XJC, radiology i. Prophylactic Occlusion Balloon Placement in the Abdominal Aorta Combined with Uterine or Ovarian Artery Embolization for the Prevention of Cesarean Hysterectomy Due to Placenta Accreta: A Retrospective Study. 2019;42(6):829-34.
51. Zheng Z, Xie X, Hou Y, Xie P, Yu X, Xie LJC, et al. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta. 2019;46(5):704.
52. Duan X, Chen P, Han X, Wang Y, Chen Z, Zhang X, et al. Intermittent aortic balloon occlusion combined with cesarean section for the treatment of patients with placenta previa complicated by placenta accreta: A retrospective study. 2018;44(9):1752-60.
53. Mei Y, Zhao H, Zhou H, Jing H, Lin YJBp, childbirth. Comparison of infrarenal aortic balloon occlusion with internal iliac artery balloon occlusion for patients with placenta accreta. 2019;19(1):147.
54. Dai Mj, Jin Gx, Lin Jh, Zhang Y, Chen Yy, Zhang XbJIJoG, et al. Pre‐cesarean prophylactic balloon placement in the internal iliac artery to prevent postpartum hemorrhage among women with pernicious placenta previa. 2018;142(3):315-20.
55. Sun W, Duan S, Xin G, Xiao J, Hong F, Hong H, et al. Safety and efficacy of preoperative abdominal aortic balloon occlusion in placenta increta and/or percreta. 2018;222:75-84.
56. Luo F, Xie L, Xie P, Liu S, Zhu YJTJoO, Gynecology. Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: a retrospective study. 2017;56(2):147-52.
57. Angileri SA, Mailli L, Raspanti C, Ierardi AM, Carrafiello G, Belli A-MJLrm. Prophylactic occlusion balloon placement in internal iliac arteries for the prevention of postpartum haemorrhage due to morbidly adherent placenta: short term outcomes. 2017;122(10):798-806.
58. Cui S, Zhi Y, Cheng G, Zhang K, Zhang L, Shen LJIJoG, et al. Retrospective analysis of placenta previa with abnormal placentation with and without prophylactic use of abdominal aorta balloon occlusion. 2017;137(3):265-70.
59. Wu Q, Liu Z, Zhao X, Liu C, Wang Y, Chu Q, et al. Outcome of pregnancies after balloon occlusion of the infrarenal abdominal aorta during caesarean in 230 patients with placenta praevia accreta. 2016;39(11):1573-9.
60. Panici PB, Anceschi M, Borgia ML, Bresadola L, Masselli G, Parasassi T, et al. Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta. 2012;25(12):2512-6.
61. Thon S, McLintic A, Wagner YJIjooa. Prophylactic endovascular placement of internal iliac occlusion balloon catheters in parturients with placenta accreta: a retrospective case series. 2011;20(1):64-70.
62. Sadashivaiah J, Wilson R, Thein A, McLure H, Hammond C, Lyons GJIjooa. Role of prophylactic uterine artery balloon catheters in the management of women with suspected placenta accreta. 2011;20(4):282-7.
63. Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. 2007;189(5):1158-63.
64. Zhao B, Lv M, Dong T, Chen Y, Xi F, Lv W, et al. Transverse parallel compression suture: a new suturing method for successful treating pernicious placenta previa during cesarean section. 2020;301(2):465-72.
65. El Gelany S, Ibrahim EM, Abdelraheim AR, Khalifa EM, Abdelhakium AK, Yousef AM, et al. Management of bleeding from morbidly adherent placenta during elective repeat caesarean section: retrospective-record-based study. 2019;19(1):106.
66. Mohamed MAJTJoM-F, Medicine N. Lower segment folding as novel technique to control bleeding in cases of morbidly adherent placenta. 2019:1-5.
67. El-Agwany ASJIJGO. Conservative treatment of placenta previa accreta with cervical isthmic opposition suturing followed by bilateral internal iliac artery ligation. 2016;135:329-30.
68. Kelekci S, Ekmekci E, Aydogmus S, Gencdal SJM. A comprehensive surgical procedure in conservative management of placenta accreta: a case series. 2015;94(7).
69. Shazly SAE, Badee AY, Ali MKJA, Obstetrics NZJo, Gynaecology. The use of multiple 8 compression suturing as a novel procedure to preserve fertility in patients with placenta accreta: case series. 2012;52(4):395-9.
70. Arduini M, Epicoco G, Clerici G, Bottaccioli E, Arena S, Affronti GJIJoG, et al. B‐Lynch suture, intrauterine balloon, and endouterine hemostatic suture for the management of postpartum hemorrhage due to placenta previa accreta. 2010;108(3):191-3.
71. Shahin AY, Farghaly TA, Mohamed SA, Shokry M, Abd‐El‐Aal DEM, Youssef MAJIJoG, et al. Bilateral uterine artery ligation plus B‐Lynch procedure for atonic postpartum hemorrhage with placenta accreta. 2010;108(3):187-90.
72. Verspyck E, Resch B, Sergent F, Marpeau LJAoegS. Surgical uterine devascularization for placenta accreta: immediate and long‐term follow‐up. 2005;84(5):444-7.
73. Palacios Jaraquemada JM, Pesaresi M, Nassif JC, Hermosid SJAoegS. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. 2004;83(8):738-44.
74. Kutuk MS, Ak M, Ozgun MTJIJoG, Obstetrics. Leaving the placenta in situ versus conservative and radical surgery in the treatment of placenta accreta spectrum disorders. 2018;140(3):338-44.
75. Provansal M, Courbiere B, Agostini A, D’Ercole C, Boubli L, Bretelle FJIJoG, et al. Fertility and obstetric outcome after conservative management of placenta accreta. 2010;109(2):147-50.
76. Bennett MJ, Townsend LJA, Obstetrics NZJo, Gynaecology. Conservative management of clinically diagnosed placenta accreta following vaginal delivery. 2009;49(6):647-9.
77. Bretelle F, Courbière B, Mazouni C, Agostini A, Cravello L, Boubli L, et al. Management of placenta accreta: morbidity and outcome. 2007;133(1):34-9.
78. Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii SJJoO, Research G. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. 2000;26(2):81-7.
79. Lin K, Qin J, Xu K, Hu W, Lin JJAog, obstetrics. Methotrexate management for placenta accreta: a prospective study. 2015;291(6):1259-64.
80. Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FAJJoP. Placenta accreta and methotrexate therapy: three case reports. 2000;20(5):331-4.
81. Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martínez M, Bruno CJTJoM-F, Medicine N. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. 2020:1-8.
82. Cırpan T, Akdemir A, Okmen F, Hortu I, Ekici H, Imamoglu MJTJoM-F, et al. Effectiveness of segmental resection technique in the treatment of placenta accreta spectrum. 2019:1-7.
83. Abo-Elroose AA-E, Ahmed MR, Shaaban MM, Ghoneim HM, Mohamed TYJTJoM-F, Medicine N. Triple P with T-shaped lower segment suture; an effective novel alternative to hysterectomy in morbidly adherent anterior placenta previa. 2019:1-5.
84. Wei Y, Cao Y, Yu Y, Wang ZJAog, obstetrics. Evaluation of a modified “Triple-P” procedure in women with morbidly adherent placenta after previous caesarean section. 2017;296(4):737-43.
85. Viñas MT, Chandraharan E, Moneta M, Belli AJCr. The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta. 2014;69(8):e345-e51.
86. Chandraharan E, Rao S, Belli AM, Arulkumaran SJIJoG, Obstetrics. The Triple‐P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. 2012;117(2):191-4.